Lobbying Relationship

Client

Coherus BioSciences, Inc

More records

Lobbying firm

INLET STRATEGIES

More records

  • S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
  • S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D

Duration: to

General Issues: Health Issues, Medicare/Medicaid

Spending: about $352,500 (But it's complicated. Here's why.)

Agencies lobbied since 2022: U.S. Senate, Health & Human Services - Dept of (HHS), House of Representatives, White House Office, Office of Management & Budget (OMB)

Bills mentioned

S.2082: MADE in America Act

Sponsor: Tim Scott (R-S.C.)

S.2082: Ensuring Justice for Victims of Terrorism Act

Sponsor: John Cornyn (R-Texas)

S.1339: Pharmacy Benefit Manager Reform Act

Sponsor: Bernard Sanders (ID-Vt.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Tom Wharton Health Legislative Assistant - Senator Joe Lieberman May 2011 - June 2012 Senior Legislative Assistant - Congressman Dan Boren July 2008 - May 2011
Thomas Wharton Legislative Assistant, Senator Lieberman. May 2011-June 2012 Senior Legislative Assistant, Representative Dan Boren July 2008-June 2011 Legislative Assistant. Senator Lieberman May 2011-June 2012 Senior Legislative Assistant. Representative Dan Boren. July 2008-June 2011

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page